AZILSARTAN KAMEDOXOMIL

AZILSARTAN KAMEDOXOMIL was reported 3052 times

These side effects are most commonly reported by patients taking AZILSARTAN KAMEDOXOMIL:

# Side effect Count
0 DIARRHOEA 169
1 HYPERTENSION 165
2 DRUG INEFFECTIVE 135
3 DIZZINESS 132
4 NAUSEA 131
5 OFF LABEL USE 115
6 FATIGUE 113
7 HEADACHE 106
8 RENAL IMPAIRMENT 100
9 MALAISE 99
10 BLOOD PRESSURE INCREASED 97
11 DECREASED APPETITE 95
12 HYPOTENSION 87
13 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 75
14 VOMITING 73
15 DYSPNOEA 70
16 ARTHRALGIA 66
17 FALL 66
18 PNEUMONIA 65
19 ACUTE KIDNEY INJURY 62
20 PYREXIA 62
21 RASH 61
22 ANAEMIA 59
23 FEELING ABNORMAL 57
24 DEATH 54
25 DEHYDRATION 54
26 ASTHENIA 53
27 BLOOD PRESSURE DECREASED 52
28 INTERSTITIAL LUNG DISEASE 52
29 MUSCLE SPASMS 51
30 PLATELET COUNT DECREASED 51
31 CONSTIPATION 48
32 BLOOD CREATININE INCREASED 47
33 CARDIAC FAILURE 47
34 PRURITUS 47
35 RENAL FAILURE 46
36 PAIN IN EXTREMITY 45
37 OEDEMA PERIPHERAL 43
38 PRODUCT ODOUR ABNORMAL 43
39 COVID-19 42
40 WEIGHT DECREASED 42
41 CEREBRAL INFARCTION 41
42 URINARY TRACT INFECTION 40
43 BACK PAIN 39
44 CONDITION AGGRAVATED 39
45 COUGH 39
46 PRODUCT DOSE OMISSION ISSUE 39
47 HYPERKALAEMIA 37
48 SOMNOLENCE 37
49 ABDOMINAL PAIN UPPER 36
50 HEPATIC FUNCTION ABNORMAL 36
51 PAIN 36
52 ATRIAL FIBRILLATION 35
53 CHRONIC KIDNEY DISEASE 35
54 PERIPHERAL SWELLING 35
55 ABDOMINAL DISCOMFORT 34
56 LOSS OF CONSCIOUSNESS 32
57 MALIGNANT NEOPLASM PROGRESSION 32
58 DRUG INTERACTION 31
59 WEIGHT INCREASED 31
60 PRODUCT USE ISSUE 29
61 HYPONATRAEMIA 28
62 HYPOTHYROIDISM 28
63 MUSCULAR WEAKNESS 28
64 HAEMOGLOBIN DECREASED 27
65 PLEURAL EFFUSION 27
66 ANXIETY 26
67 INSOMNIA 26
68 PROTEINURIA 26
69 ALOPECIA 25
70 BLOOD GLUCOSE INCREASED 25
71 CHEST PAIN 25
72 GAIT DISTURBANCE 25
73 HYPOAESTHESIA 25
74 LIVER DISORDER 25
75 GLOMERULAR FILTRATION RATE DECREASED 24
76 VISUAL IMPAIRMENT 24
77 DIABETES MELLITUS 23
78 DISEASE PROGRESSION 23
79 DYSPHAGIA 23
80 HEART RATE INCREASED 23
81 MYALGIA 23
82 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23
83 ADRENAL INSUFFICIENCY 22
84 BLOOD POTASSIUM INCREASED 22
85 CEREBRAL HAEMORRHAGE 22
86 FEBRILE NEUTROPENIA 22
87 NASOPHARYNGITIS 22
88 NEUROPATHY PERIPHERAL 22
89 OEDEMA 22
90 PRODUCT DISPENSING ERROR 22
91 SYNCOPE 22
92 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22
93 DYSPHONIA 21
94 PRODUCT QUALITY ISSUE 21
95 PRODUCT STORAGE ERROR 21
96 ALTERED STATE OF CONSCIOUSNESS 20
97 CONFUSIONAL STATE 20
98 DRY MOUTH 20
99 STOMATITIS 20
100 TREMOR 20
101 VISION BLURRED 20
102 WHITE BLOOD CELL COUNT DECREASED 20
103 ALANINE AMINOTRANSFERASE INCREASED 19
104 ERYTHEMA 19
105 HEPATIC ENZYME INCREASED 19
106 HOSPITALISATION 19
107 HYPOGLYCAEMIA 19
108 PALPITATIONS 19
109 SEPSIS 19
110 SWELLING FACE 19
111 INCORRECT PRODUCT STORAGE 18
112 PRODUCT DOSE OMISSION 18
113 PRODUCT USE IN UNAPPROVED INDICATION 18
114 TUBULOINTERSTITIAL NEPHRITIS 18
115 ABDOMINAL DISTENSION 17
116 CHOLANGITIS 17
117 HYPERHIDROSIS 17
118 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17
119 INFLUENZA 17
120 OVERDOSE 17
121 PARAESTHESIA 17
122 SEPTIC SHOCK 17
123 CARDIAC FAILURE CONGESTIVE 16
124 CYTOKINE RELEASE SYNDROME 16
125 HYPERSENSITIVITY 16
126 JOINT SWELLING 16
127 MYOCARDIAL INFARCTION 16
128 PNEUMONIA ASPIRATION 16
129 RESPIRATORY FAILURE 16
130 SEIZURE 16
131 UNDERDOSE 16
132 ARRHYTHMIA 15
133 ASPARTATE AMINOTRANSFERASE INCREASED 15
134 BLOOD POTASSIUM DECREASED 15
135 CEREBROVASCULAR ACCIDENT 15
136 DEPRESSION 15
137 DRUG-INDUCED LIVER INJURY 15
138 HYPOKALAEMIA 15
139 NEUTROPHIL COUNT DECREASED 15
140 SWELLING 15
141 ABDOMINAL PAIN 14
142 ASTHMA 14
143 BLOOD PRESSURE INADEQUATELY CONTROLLED 14
144 CELLULITIS 14
145 DRUG INTOLERANCE 14
146 HAEMORRHAGE 14
147 PANCYTOPENIA 14
148 THROMBOCYTOPENIA 14
149 URTICARIA 14
150 ANGIOEDEMA 13
151 ASCITES 13
152 BLOOD CHOLESTEROL INCREASED 13
153 BLOOD CREATINE PHOSPHOKINASE INCREASED 13
154 CARDIAC ARREST 13
155 CHILLS 13
156 CYSTITIS 13
157 DRUG DOSE OMISSION 13
158 INFECTION 13
159 MYASTHENIA GRAVIS 13
160 PEMPHIGOID 13
161 TASTE DISORDER 13
162 URINARY RETENTION 13
163 BLOOD PRESSURE FLUCTUATION 12
164 BLOOD PRESSURE SYSTOLIC INCREASED 12
165 END STAGE RENAL DISEASE 12
166 FEELING HOT 12
167 GOUT 12
168 HYPERGLYCAEMIA 12
169 INCORRECT DOSE ADMINISTERED 12
170 LETHARGY 12
171 PYELONEPHRITIS 12
172 RHABDOMYOLYSIS 12
173 TREATMENT NONCOMPLIANCE 12
174 UNEVALUABLE EVENT 12
175 BACTERAEMIA 11
176 BALANCE DISORDER 11
177 C-REACTIVE PROTEIN INCREASED 11
178 CHEST DISCOMFORT 11
179 DELIRIUM 11
180 DRUG HYPERSENSITIVITY 11
181 DRUG LEVEL INCREASED 11
182 DRY SKIN 11
183 DYSPNOEA EXERTIONAL 11
184 ENTERITIS 11
185 EPISTAXIS 11
186 EYE PAIN 11
187 FLATULENCE 11
188 GASTROINTESTINAL HAEMORRHAGE 11
189 HERPES ZOSTER 11
190 IMMUNE-MEDIATED ENTEROCOLITIS 11
191 INFUSION RELATED REACTION 11
192 INTESTINAL ISCHAEMIA 11
193 LACTIC ACIDOSIS 11
194 LIMB INJURY 11
195 MEMORY IMPAIRMENT 11
196 POLLAKIURIA 11
197 POOR QUALITY DRUG ADMINISTERED 11
198 SPEECH DISORDER 11
199 ANAPHYLACTIC REACTION 10
200 ANGINA PECTORIS 10
201 BLOOD BILIRUBIN INCREASED 10
202 BLOOD SODIUM DECREASED 10
203 BRADYCARDIA 10
204 BURNING SENSATION 10
205 CARDIAC DISORDER 10
206 CONTUSION 10
207 DYSGEUSIA 10
208 ENTEROCOLITIS 10
209 FLUID RETENTION 10
210 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10
211 HALLUCINATION 10
212 INJECTION SITE PRURITUS 10
213 INTENTIONAL PRODUCT USE ISSUE 10
214 MYELOSUPPRESSION 10
215 NEPHROGENIC ANAEMIA 10
216 PRODUCT PHYSICAL ISSUE 10
217 PULMONARY OEDEMA 10
218 RENAL DISORDER 10
219 SHOCK 10
220 SKIN EXFOLIATION 10
221 TACHYCARDIA 10
222 THERAPEUTIC RESPONSE DECREASED 10
223 THROAT TIGHTNESS 10
224 AMNESIA 9
225 COLITIS ULCERATIVE 9
226 CONTRAINDICATED PRODUCT ADMINISTERED 9
227 DRUG ERUPTION 9
228 DYSPEPSIA 9
229 ECZEMA 9
230 ERYTHEMA MULTIFORME 9
231 HYPERURICAEMIA 9
232 HYPOALBUMINAEMIA 9
233 INTENTIONAL OVERDOSE 9
234 INTENTIONAL PRODUCT MISUSE 9
235 MIGRAINE 9
236 MUSCULOSKELETAL STIFFNESS 9
237 PRODUCT SUBSTITUTION ISSUE 9
238 PULMONARY EMBOLISM 9
239 RASH PRURITIC 9
240 RHEUMATOID ARTHRITIS 9
241 SINUSITIS 9
242 SLEEP DISORDER 9
243 STRESS 9
244 TOXIC EPIDERMAL NECROLYSIS 9
245 TRANSIENT ISCHAEMIC ATTACK 9
246 APHASIA 8
247 ARTHRITIS 8
248 BLOOD UREA INCREASED 8
249 BRONCHITIS 8
250 COLITIS 8
251 CORONAVIRUS INFECTION 8
252 DEEP VEIN THROMBOSIS 8
253 DIABETIC KETOACIDOSIS 8
254 DISEASE RECURRENCE 8
255 DISTURBANCE IN ATTENTION 8
256 EYE SWELLING 8
257 FACIAL PARALYSIS 8
258 GAIT INABILITY 8
259 GASTROINTESTINAL DISORDER 8
260 GENERAL PHYSICAL HEALTH DETERIORATION 8
261 GLOSSITIS 8
262 HYPERTHYROIDISM 8
263 HYPOPHAGIA 8
264 INFLAMMATION 8
265 LIP SWELLING 8
266 METASTASES TO BONE 8
267 MYOCARDITIS 8
268 NEOPLASM PROGRESSION 8
269 NEUTROPENIA 8
270 POOR QUALITY PRODUCT ADMINISTERED 8
271 PRESCRIBED UNDERDOSE 8
272 PRODUCT CLOSURE REMOVAL DIFFICULT 8
273 RESTLESSNESS 8
274 SHOCK HAEMORRHAGIC 8
275 STEVENS-JOHNSON SYNDROME 8
276 THROMBOTIC MICROANGIOPATHY 8
277 THYROID DISORDER 8
278 ACUTE MYOCARDIAL INFARCTION 7
279 ADVERSE EVENT 7
280 ANAPHYLACTIC SHOCK 7
281 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7
282 ARTHROPATHY 7
283 BLOOD PRESSURE ABNORMAL 7
284 BRASH SYNDROME 7
285 CARDIAC FAILURE ACUTE 7
286 CHOLECYSTITIS 7
287 COGNITIVE DISORDER 7
288 CORONARY ARTERY STENOSIS 7
289 DEPRESSED LEVEL OF CONSCIOUSNESS 7
290 DEPRESSED MOOD 7
291 DIPLOPIA 7
292 DRY EYE 7
293 EXPIRED PRODUCT ADMINISTERED 7
294 FLUSHING 7
295 FULMINANT TYPE 1 DIABETES MELLITUS 7
296 GASTRIC ULCER HAEMORRHAGE 7
297 GLYCOSYLATED HAEMOGLOBIN INCREASED 7
298 HAEMATOCHEZIA 7
299 HEART RATE DECREASED 7
300 HOT FLUSH 7
301 HYDRONEPHROSIS 7
302 IMMUNE-MEDIATED MYOSITIS 7
303 INJECTION SITE PAIN 7
304 JOINT STIFFNESS 7
305 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7
306 NEPHROLITHIASIS 7
307 NEPHROTIC SYNDROME 7
308 PANCREATITIS ACUTE 7
309 PERICARDIAL EFFUSION 7
310 PHARYNGEAL OEDEMA 7
311 PNEUMOCYSTIS JIROVECII PNEUMONIA 7
312 PNEUMONIA BACTERIAL 7
313 PRODUCT CONTAMINATION 7
314 PULMONARY TOXICITY 7
315 RHINORRHOEA 7
316 SKIN DISORDER 7
317 SKIN ULCER 7
318 SUBDURAL HAEMATOMA 7
319 THERAPY CESSATION 7
320 TINNITUS 7
321 VERTIGO 7
322 BACTERIAL INFECTION 6
323 BLISTER 6
324 BONE PAIN 6
325 BRONCHOPULMONARY ASPERGILLOSIS 6
326 CARDIAC FAILURE CHRONIC 6
327 CARDIO-RESPIRATORY ARREST 6
328 CHOKING 6
329 DEMENTIA 6
330 DIABETES MELLITUS INADEQUATE CONTROL 6
331 DISSEMINATED INTRAVASCULAR COAGULATION 6
332 DYSKINESIA 6
333 ELECTROCARDIOGRAM QT PROLONGED 6
334 FEEDING DISORDER 6
335 GASTRIC CANCER 6
336 GASTROOESOPHAGEAL REFLUX DISEASE 6
337 HYPERPARATHYROIDISM SECONDARY 6
338 HYPOCALCAEMIA 6
339 ILEUS PARALYTIC 6
340 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 6
341 IMMUNE-MEDIATED HEPATIC DISORDER 6
342 IMMUNE-MEDIATED LUNG DISEASE 6
343 IMPAIRED HEALING 6
344 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
345 INJECTION SITE ERYTHEMA 6
346 INJECTION SITE SWELLING 6
347 INTENTIONAL DOSE OMISSION 6
348 IRON DEFICIENCY ANAEMIA 6
349 IRRITABLE BOWEL SYNDROME 6
350 LEUKOCYTOSIS 6
351 LIVER FUNCTION TEST ABNORMAL 6
352 METABOLIC ALKALOSIS 6
353 MICROANGIOPATHY 6
354 MOBILITY DECREASED 6
355 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
356 NECK PAIN 6
357 NO ADVERSE EVENT 6
358 ORGANISING PNEUMONIA 6
359 OROPHARYNGEAL PAIN 6
360 OSTEONECROSIS OF JAW 6
361 OSTEOPOROSIS 6
362 OXYGEN SATURATION DECREASED 6
363 PERIPHERAL SENSORY NEUROPATHY 6
364 PHYSICAL DECONDITIONING 6
365 PRODUCT AVAILABILITY ISSUE 6
366 PRODUCT TASTE ABNORMAL 6
367 PRODUCT USE COMPLAINT 6
368 PSORIASIS 6
369 RASH GENERALISED 6
370 RENAL CYST 6
371 SKIN DISCOLOURATION 6
372 SUBARACHNOID HAEMORRHAGE 6
373 SURGERY 6
374 THERAPEUTIC PRODUCT EFFECT DECREASED 6
375 THERAPY INTERRUPTED 6
376 THERAPY PARTIAL RESPONDER 6
377 THINKING ABNORMAL 6
378 THIRST 6
379 THROMBOSIS 6
380 TOXICITY TO VARIOUS AGENTS 6
381 WHITE BLOOD CELL COUNT INCREASED 6
382 ANAL INCONTINENCE 5
383 AORTIC DISSECTION 5
384 ARTERIOSCLEROSIS 5
385 ASPIRATION 5
386 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5
387 BLOOD PRESSURE DIASTOLIC DECREASED 5
388 BLOOD TRIGLYCERIDES INCREASED 5
389 BLOOD URIC ACID INCREASED 5
390 BONE MARROW FAILURE 5
391 CARDIAC TAMPONADE 5
392 CARPAL TUNNEL SYNDROME 5
393 CHOLELITHIASIS 5
394 CHROMATURIA 5
395 COLON CANCER 5
396 COMPRESSION FRACTURE 5
397 COVID-19 PNEUMONIA 5
398 DEAFNESS 5
399 DISCOMFORT 5
400 DISORIENTATION 5
401 DRUG DISPENSING ERROR 5
402 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5
403 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5
404 DYSLALIA 5
405 DYSLIPIDAEMIA 5
406 EATING DISORDER 5
407 EMOTIONAL DISTRESS 5
408 EOSINOPHIL COUNT INCREASED 5
409 EPILEPSY 5
410 EUGLYCAEMIC DIABETIC KETOACIDOSIS 5
411 EYE DISORDER 5
412 FOCAL PERITONITIS 5
413 GASTRITIS 5
414 GASTROINTESTINAL HYPOMOTILITY 5
415 HAEMOPTYSIS 5
416 HEAD DISCOMFORT 5
417 HEART RATE IRREGULAR 5
418 HEPATIC FAILURE 5
419 HYPERBILIRUBINAEMIA 5
420 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5
421 INCONTINENCE 5
422 INJECTION SITE INDURATION 5
423 INTERNAL HAEMORRHAGE 5
424 KL-6 INCREASED 5
425 KNEE OPERATION 5
426 LACRIMATION INCREASED 5
427 LACUNAR INFARCTION 5
428 LIMB DISCOMFORT 5
429 LIVER FUNCTION TEST INCREASED 5
430 LUNG NEOPLASM MALIGNANT 5
431 LUNG OPACITY 5
432 LYMPHADENOPATHY 5
433 LYMPHANGIOSIS CARCINOMATOSA 5
434 LYMPHOCYTE COUNT DECREASED 5
435 METABOLIC ACIDOSIS 5
436 METASTASES TO LIVER 5
437 METASTASES TO LYMPH NODES 5
438 MUSCLE TIGHTNESS 5
439 NEOPLASM MALIGNANT 5
440 NEPHROPATHY TOXIC 5
441 OCULAR HYPERAEMIA 5
442 PAIN IN JAW 5
443 PNEUMATOSIS INTESTINALIS 5
444 PNEUMONITIS 5
445 PRESYNCOPE 5
446 PRODUCT PACKAGING ISSUE 5
447 PRODUCTIVE COUGH 5
448 PROTEIN URINE PRESENT 5
449 PULMONARY ALVEOLAR HAEMORRHAGE 5
450 PURPURA 5
451 REBOUND EFFECT 5
452 RENAL INJURY 5
453 SHUNT OCCLUSION 5
454 SINUS BRADYCARDIA 5
455 SINUS DISORDER 5
456 SINUS NODE DYSFUNCTION 5
457 SKIN LACERATION 5
458 SPINAL COMPRESSION FRACTURE 5
459 SPINAL PAIN 5
460 STAPHYLOCOCCAL INFECTION 5
461 STRESS CARDIOMYOPATHY 5
462 SUICIDE ATTEMPT 5
463 SWOLLEN TONGUE 5
464 SYMPTOM RECURRENCE 5
465 THERAPEUTIC RESPONSE SHORTENED 5
466 THERAPY NON-RESPONDER 5
467 TUMOUR LYSIS SYNDROME 5
468 UPPER RESPIRATORY TRACT INFECTION 5
469 WHEEZING 5
470 WOUND INFECTION 5
471 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 4
472 ADVERSE DRUG REACTION 4
473 AMYLASE INCREASED 4
474 AORTIC VALVE STENOSIS 4
475 ASPHYXIA 4
476 ATRIOVENTRICULAR BLOCK COMPLETE 4
477 AUTOIMMUNE DISORDER 4
478 BENIGN PROSTATIC HYPERPLASIA 4
479 BILE DUCT STONE 4
480 BLADDER SPASM 4
481 BLOOD ALBUMIN DECREASED 4
482 BLOOD CALCIUM INCREASED 4
483 BLOOD CREATINE INCREASED 4
484 BLOOD GLUCOSE DECREASED 4
485 BLOOD LACTATE DEHYDROGENASE INCREASED 4
486 BLOOD MAGNESIUM DECREASED 4
487 BRAIN NATRIURETIC PEPTIDE INCREASED 4
488 BREAST PAIN 4
489 CARDIAC DYSFUNCTION 4
490 CARDIOMYOPATHY 4
491 CEREBRAL DISORDER 4
492 CHOLANGITIS ACUTE 4
493 CHOLESTATIC LIVER INJURY 4
494 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4
495 CONVULSION 4
496 CORONARY ARTERY DISEASE 4
497 CYTOMEGALOVIRUS ENTEROCOLITIS 4
498 CYTOMEGALOVIRUS INFECTION 4
499 DEVICE DISLOCATION 4
500 DIALYSIS 4
501 DISSEMINATED CRYPTOCOCCOSIS 4
502 DIVERTICULITIS 4
503 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4
504 DRUG EFFECT INCOMPLETE 4
505 DUODENAL ULCER HAEMORRHAGE 4
506 DYSGRAPHIA 4
507 DYSSTASIA 4
508 DYSURIA 4
509 ECONOMIC PROBLEM 4
510 ELECTROLYTE IMBALANCE 4
511 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4
512 ERECTILE DYSFUNCTION 4
513 EYE DISCHARGE 4
514 EYE IRRITATION 4
515 EYELID PTOSIS 4
516 FEELING COLD 4
517 FEMUR FRACTURE 4
518 FLUID INTAKE REDUCED 4
519 FRACTURE 4
520 GASTRIC ULCER 4
521 GASTROENTERITIS 4
522 GIANT CELL ARTERITIS 4
523 GINGIVAL HYPERTROPHY 4
524 GYNAECOMASTIA 4
525 HAEMATOCRIT DECREASED 4
526 HAEMATURIA 4
527 HAEMOGLOBIN INCREASED 4
528 HAEMORRHAGE SUBCUTANEOUS 4
529 HAIR COLOUR CHANGES 4
530 HEMIPLEGIA 4
531 HEPATIC CANCER 4
532 HEPATIC CIRRHOSIS 4
533 HUMERUS FRACTURE 4
534 HYPERTENSIVE CRISIS 4
535 HYPOMAGNESAEMIA 4
536 HYPOPITUITARISM 4
537 HYPOTHERMIA 4
538 HYPOTONIA 4
539 ILEUS 4
540 ILL-DEFINED DISORDER 4
541 ILLNESS 4
542 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4
543 IMMUNE THROMBOCYTOPENIA 4
544 IMMUNE-MEDIATED HEPATITIS 4
545 IMMUNE-MEDIATED HYPOTHYROIDISM 4
546 INJECTION SITE ABSCESS 4
547 INJECTION SITE BRUISING 4
548 INJECTION SITE DISCOMFORT 4
549 INJECTION SITE NODULE 4
550 ISCHAEMIC STROKE 4
551 JOINT DISLOCATION 4
552 JOINT LOCK 4
553 LEUKOPENIA 4
554 LOSS OF BLADDER SENSATION 4
555 LOWER RESPIRATORY TRACT INFECTION 4
556 LYMPH NODE PAIN 4
557 MOVEMENT DISORDER 4
558 MULTIPLE SCLEROSIS RELAPSE 4
559 MUSCULOSKELETAL DISCOMFORT 4
560 NERVOUS SYSTEM DISORDER 4
561 NERVOUSNESS 4
562 NOCTURIA 4
563 OLIGOHYDRAMNIOS 4
564 ORAL DISCOMFORT 4
565 ORTHOSTATIC HYPOTENSION 4
566 PAIN OF SKIN 4
567 PARAESTHESIA ORAL 4
568 PEMPHIGUS 4
569 PERIODONTITIS 4
570 PNEUMONIA FUNGAL 4
571 PRERENAL FAILURE 4
572 PRESCRIBED OVERDOSE 4
573 PROCTITIS 4
574 PRODUCT COMMINGLING 4
575 PRODUCT PACKAGING QUANTITY ISSUE 4
576 PRODUCT PRESCRIBING ERROR 4
577 PSORIATIC ARTHROPATHY 4
578 PULMONARY CONGESTION 4
579 RASH ERYTHEMATOUS 4
580 RASH MACULO-PAPULAR 4
581 RASH PAPULAR 4
582 RENAL ATROPHY 4
583 RENAL CELL CARCINOMA 4
584 RESPIRATORY DISORDER 4
585 RESPIRATORY MUSCLE WEAKNESS 4
586 RETCHING 4
587 RIB FRACTURE 4
588 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4
589 SENSORY LOSS 4
590 SKIN ODOUR ABNORMAL 4
591 SLEEP APNOEA SYNDROME 4
592 SLUGGISHNESS 4
593 SPINAL FRACTURE 4
594 SQUAMOUS CELL CARCINOMA 4
595 SUDDEN DEATH 4
596 THALAMUS HAEMORRHAGE 4
597 THERAPEUTIC RESPONSE UNEXPECTED 4
598 THROAT IRRITATION 4
599 THROMBOSIS IN DEVICE 4
600 THROMBOTIC CEREBRAL INFARCTION 4
601 THYROIDITIS 4
602 URINE OUTPUT DECREASED 4
603 VENTRICULAR EXTRASYSTOLES 4
604 VENTRICULAR FIBRILLATION 4
605 WITHDRAWAL HYPERTENSION 4
606 WOUND 4
607 ABASIA 3
608 ABDOMINAL PAIN LOWER 3
609 ACTIVITIES OF DAILY LIVING IMPAIRED 3
610 ACUTE RESPIRATORY DISTRESS SYNDROME 3
611 ADMINISTRATION SITE PAIN 3
612 ADRENOCORTICAL INSUFFICIENCY ACUTE 3
613 AGRANULOCYTOSIS 3
614 ANGINA UNSTABLE 3
615 ANHEDONIA 3
616 APPENDICITIS 3
617 ARTHROPOD BITE 3
618 ATAXIA 3
619 BLINDNESS 3
620 BLOOD ALKALINE PHOSPHATASE INCREASED 3
621 BLOOD GLUCOSE FLUCTUATION 3
622 BLOOD SODIUM INCREASED 3
623 BREAST CANCER 3
624 BUNDLE BRANCH BLOCK RIGHT 3
625 CARDIOMEGALY 3
626 CATARACT 3
627 CEREBELLAR HAEMORRHAGE 3
628 CHOLECYSTITIS INFECTIVE 3
629 CONCOMITANT DISEASE AGGRAVATED 3
630 CROHN^S DISEASE 3
631 CUTANEOUS VASCULITIS 3
632 CYST 3
633 DERMATITIS 3
634 DERMATITIS ATOPIC 3
635 DERMATITIS BULLOUS 3
636 DEVICE RELATED INFECTION 3
637 DIABETIC RETINOPATHY 3
638 DRUG ADMINISTRATION ERROR 3
639 DRUG EFFECT DECREASED 3
640 DRY THROAT 3
641 DYSARTHRIA 3
642 EMBOLISM 3
643 ENCEPHALOPATHY 3
644 EOSINOPHILIC PNEUMONIA 3
645 EPIGASTRIC DISCOMFORT 3
646 EYE PRURITUS 3
647 FAECES DISCOLOURED 3
648 FEMORAL NECK FRACTURE 3
649 FULL BLOOD COUNT DECREASED 3
650 FUNGAL INFECTION 3
651 GASTRIC DISORDER 3
652 GASTROENTERITIS VIRAL 3
653 GENERALISED TONIC-CLONIC SEIZURE 3
654 GLAUCOMA 3
655 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 3
656 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3
657 HAEMOTHORAX 3
658 HALLUCINATION, VISUAL 3
659 HEPATIC ENCEPHALOPATHY 3
660 HIGH DENSITY LIPOPROTEIN DECREASED 3
661 HYPERADRENALISM 3
662 HYPERCALCAEMIA 3
663 HYPERCAPNIA 3
664 HYPERCHOLESTEROLAEMIA 3
665 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3
666 HYPERNATRAEMIA 3
667 HYPOACUSIS 3
668 IMMOBILISATION SYNDROME 3
669 IMMUNE SYSTEM DISORDER 3
670 IMMUNE-MEDIATED MYOCARDITIS 3
671 INCORRECT PRODUCT ADMINISTRATION DURATION 3
672 INFECTION SUSCEPTIBILITY INCREASED 3
673 INFLUENZA LIKE ILLNESS 3
674 INJECTION SITE HAEMORRHAGE 3
675 INJURY 3
676 INTERNATIONAL NORMALISED RATIO INCREASED 3
677 INTESTINAL OBSTRUCTION 3
678 IRRITABILITY 3
679 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3
680 LARGE INTESTINE POLYP 3
681 LIPASE INCREASED 3
682 LOWER GASTROINTESTINAL HAEMORRHAGE 3
683 MARASMUS 3
684 MASTICATION DISORDER 3
685 MECHANICAL ILEUS 3
686 MENTAL DISORDER 3
687 MENTAL IMPAIRMENT 3
688 METASTASES TO CENTRAL NERVOUS SYSTEM 3
689 METASTASES TO PERITONEUM 3
690 MIDDLE INSOMNIA 3
691 MITRAL VALVE INCOMPETENCE 3
692 MUSCULOSKELETAL PAIN 3
693 NASAL CONGESTION 3
694 NEPHROPATHY 3
695 NON-SMALL CELL LUNG CANCER 3
696 NORMOCYTIC ANAEMIA 3
697 OBESITY 3
698 OESOPHAGEAL ULCER 3
699 ORAL PAIN 3
700 OSTEOARTHRITIS 3
701 OSTEOMYELITIS 3
702 PANCREATITIS 3
703 PERFORMANCE STATUS DECREASED 3
704 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3
705 PLASMA CELL MYELOMA 3
706 PLEURISY 3
707 PLEURISY BACTERIAL 3
708 PNEUMONIA CRYPTOCOCCAL 3
709 PNEUMOTHORAX 3
710 POLYP 3
711 POOR QUALITY SLEEP 3
712 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3
713 POTENTIATING DRUG INTERACTION 3
714 PREMATURE RUPTURE OF MEMBRANES 3
715 PRODUCT SIZE ISSUE 3
716 PROSTATE CANCER 3
717 PSYCHOMOTOR HYPERACTIVITY 3
718 PULMONARY FIBROSIS 3
719 PULMONARY HYPERTENSION 3
720 PYELOCALIECTASIS 3
721 RASH MACULAR 3
722 RECTAL CANCER 3
723 RECTAL HAEMORRHAGE 3
724 RENAL FAILURE ACUTE 3
725 RENAL INFARCT 3
726 RENAL TUBULAR DISORDER 3
727 RESPIRATORY TRACT INFECTION 3
728 ROTATOR CUFF SYNDROME 3
729 SARS-COV-2 TEST POSITIVE 3
730 SCIATICA 3
731 SINUS TACHYCARDIA 3
732 SKIN BURNING SENSATION 3
733 SKIN FISSURES 3
734 SPINAL OPERATION 3
735 SPRUE-LIKE ENTEROPATHY 3
736 SPUTUM RETENTION 3
737 SUBCUTANEOUS EMPHYSEMA 3
738 SUDDEN HEARING LOSS 3
739 SUPRAVENTRICULAR TACHYCARDIA 3
740 SUSPECTED DRUG-INDUCED LIVER INJURY 3
741 TOOTH EXTRACTION 3
742 TOXIC ENCEPHALOPATHY 3
743 TYPE 1 DIABETES MELLITUS 3
744 TYPE 2 DIABETES MELLITUS 3
745 UPPER LIMB FRACTURE 3
746 URETEROLITHIASIS 3
747 URINE ALBUMIN/CREATININE RATIO INCREASED 3
748 VASCULAR DEVICE INFECTION 3
749 VASCULAR OCCLUSION 3
750 VASCULAR PSEUDOANEURYSM 3
751 VENTRICULAR TACHYCARDIA 3
752 VISUAL FIELD DEFECT 3
753 ZINC DEFICIENCY 3
754 ABNORMAL DREAMS 2
755 ABNORMAL SENSATION IN EYE 2
756 ABSCESS 2
757 ACCIDENTAL OVERDOSE 2
758 ACNE 2
759 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2
760 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2
761 ADMINISTRATION SITE HAEMATOMA 2
762 ADRENAL DISORDER 2
763 AGITATION 2
764 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2
765 AMMONIA INCREASED 2
766 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 2
767 ANEURYSM 2
768 ANEURYSM RUPTURED 2
769 ANGER 2
770 ANGLE CLOSURE GLAUCOMA 2
771 APATHY 2
772 APHONIA 2
773 APLASTIC ANAEMIA 2
774 APPENDICITIS PERFORATED 2
775 APPETITE DISORDER 2
776 APPLICATION SITE PAIN 2
777 APPLICATION SITE PRURITUS 2
778 ARTERIAL INJURY 2
779 ASPARTATE AMINOTRANSFERASE ABNORMAL 2
780 ASTHENOPIA 2
781 ATRIOVENTRICULAR BLOCK 2
782 AUTOIMMUNE HEPATITIS 2
783 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2
784 AZOTAEMIA 2
785 BACK DISORDER 2
786 BASAL CELL CARCINOMA 2
787 BLADDER DISORDER 2
788 BLINDNESS UNILATERAL 2
789 BLOOD CALCIUM DECREASED 2
790 BLOOD GLUCOSE ABNORMAL 2
791 BLOOD PARATHYROID HORMONE DECREASED 2
792 BLOOD PRESSURE DIASTOLIC INCREASED 2
793 BLOOD PRESSURE SYSTOLIC DECREASED 2
794 BLOOD THYROID STIMULATING HORMONE INCREASED 2
795 BLOOD UREA ABNORMAL 2
796 BODY TEMPERATURE INCREASED 2
797 BRAIN FOG 2
798 BREAST CANCER FEMALE 2
799 BREAST CYST 2
800 BRONCHOPNEUMONIA 2
801 BRONCHOSPASM 2
802 BUNDLE BRANCH BLOCK LEFT 2
803 CALCULUS BLADDER 2
804 CANCER PAIN 2
805 CARDIAC FLUTTER 2
806 CARDIOGENIC SHOCK 2
807 CAROTID ARTERIOSCLEROSIS 2
808 CAROTID ARTERY OCCLUSION 2
809 CATARACT OPERATION 2
810 CENTRAL OBESITY 2
811 CEREBRAL HAEMATOMA 2
812 CHOLECYSTITIS ACUTE 2
813 CHRONIC GASTRITIS 2
814 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2
815 CIRCULATORY COLLAPSE 2
816 CLOSTRIDIUM DIFFICILE INFECTION 2
817 COAGULOPATHY 2
818 COLITIS MICROSCOPIC 2
819 COMPARTMENT SYNDROME 2
820 CONCOMITANT DISEASE PROGRESSION 2
821 COORDINATION ABNORMAL 2
822 CORONARY ARTERY OCCLUSION 2
823 COUGH VARIANT ASTHMA 2
824 CREATININE RENAL CLEARANCE DECREASED 2
825 CRYPTOCOCCAL MENINGOENCEPHALITIS 2
826 CYANOSIS 2
827 CYTOPENIA 2
828 DACRYOSTENOSIS ACQUIRED 2
829 DECREASED ACTIVITY 2
830 DECREASED IMMUNE RESPONSIVENESS 2
831 DECUBITUS ULCER 2
832 DEMENTIA ALZHEIMER^S TYPE 2
833 DERMAL CYST 2
834 DERMATITIS ACNEIFORM 2
835 DERMATITIS ALLERGIC 2
836 DERMATITIS CONTACT 2
837 DEVICE ISSUE 2
838 DIABETIC FOOT 2
839 DIABETIC NEPHROPATHY 2
840 DIABETIC NEUROPATHY 2
841 DISABILITY 2
842 DIZZINESS POSTURAL 2
843 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2
844 DRUG LEVEL DECREASED 2
845 DRUG RESISTANCE 2
846 DUODENAL ULCER 2
847 DUODENAL ULCER PERFORATION 2
848 EAR DISCOMFORT 2
849 EOSINOPHILIA 2
850 ERUCTATION 2
851 EXERCISE TOLERANCE DECREASED 2
852 EXPOSURE DURING PREGNANCY 2
853 EYE HAEMORRHAGE 2
854 EYELID OEDEMA 2
855 EYELID PAIN 2
856 FANCONI SYNDROME 2
857 FEAR 2
858 FIBULA FRACTURE 2
859 FOETAL EXPOSURE DURING PREGNANCY 2
860 FOETAL HEART RATE DECELERATION ABNORMALITY 2
861 FOOD ALLERGY 2
862 FOOT FRACTURE 2
863 FOREIGN BODY 2
864 FOURNIER^S GANGRENE 2
865 FREQUENT BOWEL MOVEMENTS 2
866 FURUNCLE 2
867 GASTRIC HAEMORRHAGE 2
868 GASTRIC POLYPS 2
869 GASTROENTERITIS EOSINOPHILIC 2
870 GASTROINTESTINAL OEDEMA 2
871 GLOMERULAR FILTRATION RATE ABNORMAL 2
872 GLOMERULONEPHRITIS MEMBRANOUS 2
873 GLOSSODYNIA 2
874 GLUCOSE URINE PRESENT 2
875 GOITRE 2
876 GRANULOCYTOPENIA 2
877 GRIP STRENGTH DECREASED 2
878 GROIN PAIN 2
879 HAEMATEMESIS 2
880 HAEMATOLOGICAL INFECTION 2
881 HAEMATOMA 2
882 HAEMATOMA MUSCLE 2
883 HAEMORRHAGE INTRACRANIAL 2
884 HAEMORRHAGIC ANAEMIA 2
885 HAEMORRHAGIC DIATHESIS 2
886 HAIR TEXTURE ABNORMAL 2
887 HEAD INJURY 2
888 HEAT ILLNESS 2
889 HEPATIC CYST 2
890 HEPATIC STEATOSIS 2
891 HEPATITIS 2
892 HICCUPS 2
893 HIP ARTHROPLASTY 2
894 HYDROCEPHALUS 2
895 HYPERPHOSPHATAEMIA 2
896 HYPERPLASIA 2
897 HYPERTENSIVE EMERGENCY 2
898 HYPERTONIC BLADDER 2
899 HYPERVOLAEMIA 2
900 HYPOCHLORAEMIA 2
901 HYPOPHARYNGEAL CANCER 2
902 HYPOPHOSPHATAEMIA 2
903 HYPOXIA 2
904 IDIOPATHIC PULMONARY FIBROSIS 2
905 IMMOBILE 2
906 IMMUNE-MEDIATED CHOLANGITIS 2
907 IMMUNE-MEDIATED DERMATITIS 2
908 IMMUNE-MEDIATED RENAL DISORDER 2
909 IMMUNE-MEDIATED THYROIDITIS 2
910 IMMUNODEFICIENCY 2
911 INABILITY TO AFFORD MEDICATION 2
912 INCREASED TENDENCY TO BRUISE 2
913 INDURATION 2
914 INFUSION SITE EXTRAVASATION 2
915 INJECTION SITE PAPULE 2
916 INJECTION SITE REACTION 2
917 INJECTION SITE WARMTH 2
918 INNER EAR DISORDER 2
919 INTENTIONAL SELF-INJURY 2
920 INTERCEPTED PRODUCT PRESCRIBING ERROR 2
921 INTERMITTENT CLAUDICATION 2
922 INTRACARDIAC THROMBUS 2
923 JAUNDICE 2
924 JAUNDICE CHOLESTATIC 2
925 JUGULAR VEIN THROMBOSIS 2
926 KNEE ARTHROPLASTY 2
927 LACTOSE INTOLERANCE 2
928 LARYNGEAL OEDEMA 2
929 LEFT VENTRICULAR DYSFUNCTION 2
930 LEFT VENTRICULAR HYPERTROPHY 2
931 LOW DENSITY LIPOPROTEIN INCREASED 2
932 LOWER LIMB FRACTURE 2
933 LUMBAR SPINAL STENOSIS 2
934 LYMPHOCYTE MORPHOLOGY ABNORMAL 2
935 MALE SEXUAL DYSFUNCTION 2
936 MEDICATION ERROR 2
937 MELAENA 2
938 MENTAL STATUS CHANGES 2
939 METASTATIC RENAL CELL CARCINOMA 2
940 MONOPLEGIA 2
941 MOOD SWINGS 2
942 MOTOR DYSFUNCTION 2
943 MOUTH HAEMORRHAGE 2
944 MOUTH SWELLING 2
945 MOUTH ULCERATION 2
946 MULTIPLE SCLEROSIS 2
947 MUSCLE ATROPHY 2
948 MUSCLE SWELLING 2
949 MUSCLE TWITCHING 2
950 MUSCULOSKELETAL CHEST PAIN 2
951 MYASTHENIC SYNDROME 2
952 MYELOFIBROSIS 2
953 MYOSITIS 2
954 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2
955 NASAL DRYNESS 2
956 NECROTISING FASCIITIS 2
957 NEOPLASM 2
958 NERVE COMPRESSION 2
959 NIGHT SWEATS 2
960 NON-CARDIAC CHEST PAIN 2
961 OCULAR DISCOMFORT 2
962 OCULOMUCOCUTANEOUS SYNDROME 2
963 ORAL DISORDER 2
964 ORAL HERPES 2
965 ORTHOPNOEA 2
966 OSTEOPENIA 2
967 PALLOR 2
968 PARALYSIS 2
969 PAROSMIA 2
970 PELVIC FRACTURE 2
971 PERIPHERAL ARTERY OCCLUSION 2
972 PERITONITIS 2
973 PERITONITIS LUPUS 2
974 PERONEAL NERVE PALSY 2
975 PERSISTENT POSTURAL-PERCEPTUAL DIZZINESS 2
976 PHARYNGEAL SWELLING 2
977 PNEUMOMEDIASTINUM 2
978 PNEUMONIA INFLUENZAL 2
979 PNEUMONIA STREPTOCOCCAL 2
980 POISONING 2
981 POLYDIPSIA 2
982 POLYURIA 2
983 PORTAL VEIN THROMBOSIS 2
984 PRIAPISM 2
985 PROCALCITONIN INCREASED 2
986 PROCTALGIA 2
987 PRODUCT ADHESION ISSUE 2
988 PRODUCT ADMINISTRATION ERROR 2
989 PRODUCT CONTAINER ISSUE 2
990 PRODUCT DISPENSING ISSUE 2
991 PRODUCT DOSE OMISSION IN ERROR 2
992 PRODUCT PACKAGING DIFFICULT TO OPEN 2
993 PRODUCT SELECTION ERROR 2
994 PROSTATIC SPECIFIC ANTIGEN INCREASED 2
995 PSEUDOALDOSTERONISM 2
996 PSYCHIATRIC SYMPTOM 2
997 PUSTULE 2
998 RADIATION PNEUMONITIS 2
999 REACTION TO EXCIPIENT 2